http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-19152-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1c0c6ba4bc47404b33afbbabb8fea7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f3522563627d9178e5ca7a2deee1cc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a0f14e21f706b77552b8eff3d90bbe5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7ff10cc49d9af894fd151d29bf69d7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c01b8e02911942665be63683e85b17c1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 |
| filingDate | 2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2781df54de69d965ff28a3e4ea42ef5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76c648537638e5afffc4d6adf697a003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9196c4668c7cf67904a2fcf1498905 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d15953cd3f670bd47060593332102ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_490654461196cf11aed627a997c11a90 |
| publicationDate | 2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-19152-U |
| titleOfInvention | Method for treating destructive pancreatitis |
| abstract | The method for treating the destructive pancreatitis comprises laparotomy, the drainage of the omental bursa through the dissected gastrocolic ligament, the marsupialization of the omental bursa, the postoperative administration of antibiotics, inhibitors of proteolysis and spasmolytics. The intraarterial catheter is extended outside to the skin through the additional puncture of the abdominal wall in such a way that the proximal segment of the gastro-omental artery locates over the aponeurosis level of the external oblique muscle of the abdomen in the subcutaneous fat. The catheter is fixed to the skin with the aid of the additional sutures. Postoperatively, the following drugs are administered intra-arterially: Ceftriaxon 2.0 + Dexamethason 8 mg + Lidocaine 20 mg + 0.9% solution of sodium chloride to 50 mL in the mode of continuous 8-hour infusion for 5-7 days. |
| priorityDate | 2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.